Learn 3 Ways to Optimize Your Companion Diagnostic Strategy

Propel Your Clinical Development Program with Proven Companion Diagnostic Strategies

The development of biomarkers and companion diagnostics is an integral component in drug development programs, especially for personalized medicines. You need one global partner with a deep understanding of clinical development, diagnostic development, regulatory requirements and strategic partnership models to ensure you achieve better outcomes.

Download our new CDx infographic to learn how our most trusted scientific experts can help you:
  • Simplify and align co-development strategies
  • Accelerate your time to market
  • Increase the probability of regulatory and commercial success
Contact us today to learn how we can put our experience and expertise to work for you by ensuring success in your next companion diagnostic development program.
Companion Diagnostic Development: Current trends and recommendations

Q2 Solutions Oncology Infographic

Providing one global lab partner to support your oncology research from discovery to post-market

Genomic Based Solutions for Your Immuno-oncology Drug Development Needs

Genomics-based biomarker approach

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

From eligibility to CDx: developing and implementing effective biomarker strategies for Immuno-oncology trials

Read More